Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 3 (2006), Issue 1 (January)

1. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
   J Med Chem, 49(1): 179-85. [Abstract] [Full-text]
2. Screening for lung cancer using low dose CT scanning: results of 2 year follow up.
   Thorax, 61(1): 54-6. [Abstract] [Full-text]
3. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer.
   Thorax, 61(1): 57-60. [Abstract] [Full-text]
4. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
   Oncogene, 25(1): 130-8. [Abstract] [Full-text]
5. Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors.
   J Clin Oncol, 24(2): 306-14. [Abstract] [Full-text]
6. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
   Br J Cancer, 94(1): 128-35. [Abstract] [Full-text]
7. Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?
   Br J Cancer, 94(1): 51-4. [Abstract] [Full-text]
8. Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.
   Br J Cancer, 94(1): 18-21. [Abstract] [Full-text]
9. Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR.
   Cancer Immunol Immunother, 55(4): 386-93. [Abstract] [Full-text]
10. High expression of shMDG1 gene is associated with low metastatic potential of tumor cells.
    Oncogene, 25(2): 317-22. [Abstract] [Full-text]
11. Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers.
    Oncogene, 25(2): 271-7. [Abstract] [Full-text]
12. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
    J Clin Oncol, 24(3): 419-30. [Abstract] [Full-text]
13. Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B.
    J Clin Oncol, 24(3): 407-12. [Abstract] [Full-text]
14. The effect of race on invasive staging and surgery in non-small-cell lung cancer.
    J Clin Oncol, 24(3): 413-8. [Abstract] [Full-text]
15. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Oncogene, 25(3): 470-9. [Abstract] [Full-text]
16. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.
    Cancer Res, 66(2): 1096-104. [Abstract] [Full-text]
17. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway.
    Cancer Res, 66(2): 1089-95. [Abstract] [Full-text]
18. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
    Cancer Res, 66(2): 944-50. [Abstract] [Full-text]
19. Acute myocardial infarction caused by coronary tumor thromboembolism: a rare primary manifestation of malignant tumor disease.
    Hum Pathol, 37(2): 236-8. [Abstract] [Full-text]
20. Modulation of TCA cycle enzymes and electron transport chain systems in experimental lung cancer.
    Life Sci, 78(9): 1010-4. [Abstract] [Full-text]
21. Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo(a)pyrene induced experimental lung cancer.
    Chem Biol Interact, 159(3): 180-5. [Abstract] [Full-text]
22. Ethnic and racial differences in the smoking-related risk of lung cancer.
    N Engl J Med, 354(4): 333-42. [Abstract] [Full-text]
23. Structure-activity studies of quinuclidinone analogs as anti-proliferative agents in lung cancer cell lines.
    Bioorg Med Chem Lett, 16(5): 1156-9. [Abstract] [Full-text]
24. Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis.
    Thorax, 61(2): 140-5. [Abstract] [Full-text]
25. FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.
    Int J Cancer, 118(7): 1692-8. [Abstract] [Full-text]
26. Bulky DNA adducts as risk indicator of lung cancer in a Danish case-cohort study.
    Int J Cancer, 118(7): 1618-22. [Abstract] [Full-text]
27. Never smokers and lung cancer risk: a case-control study of epidemiological factors.
    Int J Cancer, 118(7): 1798-804. [Abstract] [Full-text]
28. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.
    J Clin Oncol, 24(4): 688-94. [Abstract] [Full-text]
29. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
    J Clin Oncol, 24(4): 681-7. [Abstract] [Full-text]
30. Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?
    Expert Rev Anticancer Ther, 6(2): 165-73. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.